Extract from the Register of European Patents

EP Citations: EP3681516

Cited inSearch
Type:Patent literature
Publication No.:WO2010083615  [XI]
 (PROTIVA BIOTHERAPEUTICS INC et al.) [X] 1 * page 24 - pages 31,119; claims 1,9,10; table 7; compound 438 *[I] 1,3-4,6,8-12,14-16,21-23
Type:Patent literature
Publication No.:WO2016011123  [I]
 (ARROWHEAD RES CORP et al.) [I] 1,3-4,6,8-12,14-16,21-23 * page 20 - page 21; claim 1; table 3; sequences 133-136,253,253 *
Type:Patent literature
Publication No.:WO2016081444  [I]
 (ALNYLAM PHARMACEUTICALS INC et al.) [I] 1,3-4,6,8-12,14-16,21-23 * claim 2; sequences 228,590 *
Cited inInternational search
Type:Patent literature
Publication No.:US2016122761  [X]
 (PRAKASH THAZHA P et al.) [X] 1-3 * Abstract; Claim 111; para [0257]; para [0684] *
Type:Patent literature
Publication No.:WO2013165816  [A]
 (MERCK SHARP & DOHME et al.) [A] 1-3 * entire document *
Cited inExamination
Type:Patent literature
Publication No.:WO2014205451  
Type:Non-patent literature
Publication information:  AMARZGUIOUI M ET AL: "Tolerance for mutations and chemical modifications in a siRNA", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, GB, vol. 31, no. 2, 15 January 2003 (2003-01-15), pages 589 - 595, XP002281440, ISSN: 0305-1048, DOI: 10.1093/NAR/GKG147
DOI: http://dx.doi.org/10.1093/nar/gkg147